PLIN5 and fatty liver disease: LSDP5 mRNA and/or protein levels are upregulated in different animal models with FL (e.g., rat fed an HFD, mice with FL dystrophy, and mice with β3 adrenergic receptor agonist-induced acute hepatic steatosis) [42–44].